Dublin - Research and Markets has announced the addition of Hematological
Cancer Therapeutics: Pipelines and Competition to their offering.
Blood cancers include leukemia, lymphoma, and multiple myeloma. Collectively,
these cancers are the fifth most commonly occurring cancers and the second
leading cause of cancer death. Hematological Cancer Therapeutics: Pipelines
and Competition provides a realistic assessment of how newly-approved drugs
and candidates in development will impact this sector of the cancer treatment
field within the next decade.
The report reviews the activities of the leading companies in this arena
and provides a market assessment for all companies currently competing in
or contemplating entering the field.
The major strides are being made in small specialist companies with a broad
range of compounds in Phases I- III. However, the potential exists for large
international companies to enter the market as candidates from niche companies
reach later stages and prove useful in a broader context of cancer, as very
frequently is the case.
Some evidence from observation and studies seem to indicate that non-steroidal
anti-inflammatory drugs can lower the risk of colorectal cancer. Does this
mean you should take an aspirin every day to reduce your risk of colorectal
cancer or prevent it? Well it could be said that it would help and research
seems to point to that fact. Of course it would not have to be aspirin, it
could be Motrin, Advil or a host of other such over the counter type drugs.
Are researchers and doctors recommending this? No they will not go so far
as to recommend you take them, unless you are perhaps in an extremely high-risk
category. However the studies look to be pretty conclusive in fact go so
far as to say they you reduce your risk of colorectal cancer by a little
over 50%, which is a huge amount if you start to think about something so
simple reducing the risks by that wide of a margin. A weekly usage and the
number of years taken seemed to be the key. Too much usage can cause intestinal
bleeding and that is a horrible side effect; so do not try this. But the
study is interesting indeed.
Much research is continuing in the study of colorectal cancer as it kills
about 56,000 Americans per year and about 145,000 are diagnosed now every
year. The 20-year study was done on over 83,000 women between the ages of
30 and 55. These women who used aspirin only had a 23 percent less likelihood
of colorectal cancer as opposed to those who were non-aspirin users.
While the evidence suggests a reduction in the risk of colorectal cancer
from such drugs, it is probably not a good strategy to prevent colorectal
cancer. You will need to do your own research and ask your doctor about such
things, however this is a very interesting finding and something think about.
DISCLAIMER
- Please note that all articles on this web site does not constitute
professional advice. All articles are intended to provide a general view
of many topical subjects from a variety of sources. We are not responsible
for the content or any sponsored links that you may choose to visit from
this web site. We suggest you to consult a solicitor and your doctor for
advice relevant to you own situation before making any important decisions.
The author is not an expert in any given field. By printing, downloading,
or using you agree to our full terms. Below is a summary of some of the terms.
If you do not agree to the full terms, do not use the information. We are
only publishers of this material, not authors. Information may have errors
or be outdated. Some information is from historical sources or represents
opinions of the author. It is for research purposes only. The information
is "AS IS", "WITH ALL FAULTS". User assumes all risk of use, damage, or injury.
You agree that we have no liability for any damages. We are not liable for
any consequential, incidental, indirect, or special damages. You indemnify
us for claims caused by you.